"Isn't One Drop Enough?"
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
A 68-year-old pseudophakic female with progressing early open-angle glaucoma, despite good adherence with her topical prostaglandin analog monotherapy, prompted a discussion on the need for further IOP reduction. The article emphasizes the importance of setting a target IOP range, reviewing drop adherence, evaluating instillation technique, and considering adjunctive therapies. It also provides insights into patient-centric approaches, recommendations for target pressure, and practical strategies for improving patient adherence.
1. Pseudophakic female with progressing early open-angle glaucoma sought further IOP reduction.2. Importance of setting a target IOP range and reviewing drop adherence.3. Recommendations for initial target pressure for primary open-angle glaucoma patients.4. Insights into the need for adjunctive therapy to achieve target IOP reduction.5. Practical strategies for improving patient adherence are crucial in glaucoma management.
